Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB122716	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		48	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736869			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799418		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122716	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		48	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736870			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799419		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122716	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		48	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736871			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799420		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122718	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736872			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799421		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122718	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736873			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799422		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122718	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736874			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799423		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122719	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		50	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736875			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799424		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122719	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		50	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736876			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799425		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122719	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		50	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736877			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799426		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122724	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736878			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799427		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122724	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736879			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799428		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122724	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736880			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799429		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122731	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736881			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799430		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122731	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736882			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799431		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122731	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736883			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799432		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736884			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799433		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736885			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799434		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736886			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799435		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736887			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799436		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736888			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799437		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736889			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799438		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736890			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799439		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736891			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799440		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736892			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799441		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122745	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		25	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736893			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799442		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122745	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		25	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736894			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799443		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122745	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		25	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736895			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799444		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736896			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799445		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736897			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799446		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736898			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799447		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122751	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		49	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736899			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799448		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122751	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		49	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736900			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799449		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122751	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		49	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736901			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799450		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736902			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799451		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736903			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799452		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736904			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799453		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122753	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		37	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736905			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799454		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122753	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		37	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736906			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799455		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122753	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		37	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736907			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799456		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122755	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		53	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736908			Whole blood		0	Days	Time of initial vaccine administration			PV2856	V2	EXP13760	ES799457		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122755	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		53	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736909			Whole blood		1	Days	Time of initial vaccine administration			PV2857	V3	EXP13760	ES799458		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
SUB122755	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		53	Years	Healthy	ARM2102	AIRFV 2011-12	SDY296	Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)	BS736910			Whole blood		7	Days	Time of initial vaccine administration			PV2859	V5	EXP13760	ES799459		OTHER	AIRFV_2011_None	ESR12849, ESR12850, ESR12851, ESR12852, ESR12853, ESR12854, ESR12855, ESR12856, ESR12857, ESR12858, ESR12859	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703270	RNA sequencing result	SDY296_EXP13760_RNA_seq.703270.tsv	SDY296_EXP13760_RNA_seq.tsv
